Canada Approves World’s First Plant-Based COVID-19 Vaccine

Canada has ordered 76 million doses of Covifenz, the main ingredient of which was manufactured in the leaves of a tobacco relative.

Feb 25, 2022

On Thursday (February 25), Health Canada, the department of the Government of Canada responsible for Canada’s national health policy, approved the world’s first plant-based COVID-19 vaccine for use in adults aged 18 to 64. Too little data exists for approval in adults over 65, the regulators concluded.  

Medicago, the Quebec-based pharmaceutical company behind the plant-based jab, has agreed to supply the Canadian government with 76 million doses of the vaccine as soon as possible, the Associated Press reports. 

https://www.the-scientist.com/news-opinion/canada-approves-world-s-first-plant-based-covid-19-vaccine-69745?utm_campaign=TS_DAILY_NEWSLETTER_2022&utm_medium=email&_hsmi=205277533&_hsenc=p2ANqtz-84KUY0bLWgq_pAiM0yMRcEeVxS_O3SVbFe95FJ3Tvpp7s4bnW-XFUbj-K1sJ9fzbwBrZ0IFLl5-_PAz6BiZY0Cdb4LfA&utm_content=205277533&utm_source=hs_email